China Animal Husbandry Industry Co., Ltd. (600195.SS) engages in the research, development, production, and distribution of animal health products and services in China. The company offers a comprehensive portfolio of veterinary pharmaceuticals, including antibiotics, vaccines, and feed additives; biological products such as poultry and livestock vaccines; nutritional supplements and premixes for animal feed; and diagnostic reagents and testing services for disease prevention and control. It operates primarily in the animal husbandry sector, serving livestock farmers, feed mills, and veterinary clinics across mainland China, with headquarters in Beijing and founded in 1998. In recent developments, the company expanded its product offerings through strategic partnerships with international biotech firms for advanced vaccine technologies in 2024; completed a funding round to support new manufacturing facilities in 2025; and launched innovative recombinant protein-based vaccines for porcine diseases amid rising demand in the swine industry.